NCT02323763

Brief Summary

The investigators propose to explore the link between bipolar disorder, anxiety, and suicide by investigating intertemporal discounting in depressed, suicidal patients with bipolar I and II disorder who have various levels of anxiety. The investigators will determine the effect of anxiety on their intertemporal discounting (small rewards now compared to larger rewards later) in a decision-making paradigm and investigate the associated functional neuroanatomy using functional magnetic resonance imaging (fMRI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 14, 2014

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 18, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 23, 2014

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 29, 2016

Completed
Last Updated

February 9, 2017

Status Verified

February 1, 2017

Enrollment Period

2.1 years

First QC Date

December 18, 2014

Last Update Submit

February 8, 2017

Conditions

Keywords

Magnetic Resonance ImagingBipolar DisorderSuicidal Ideation

Outcome Measures

Primary Outcomes (1)

  • Functional Magnetic Resonance Imaging (fMRI) to examine brain activation and differences in intertemporal discounting

    Functional Magnetic Resonance Imaging (fMRI) will be used to look at the neuroanatomy of intertemporal discounting in patients with bipolar I and II disorder

    Participants will be analyzed as quickly as possible after a screening visit, an expected average of 2 weeks

Study Arms (1)

Bipolar I or II Disorder

30 currently depressed patients with DSM-IV bipolar I and II disorder who are currently or previously suicidal will receive fMRI.

Other: fMRI Scanning

Interventions

Imaging will be performed on a 3T Siemens Trio scanner. Each MRI scanning session will last no more than 90 minutes. fMRI will be used to determine brain activation and differences in intertemporal discounting.

Bipolar I or II Disorder

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

We will recruit 30 currently depressed patients (with DSM-IV bipolar I and II disorder who are currently or previously suicidal). Enrollment will be limited to adults aged 18-65.

You may qualify if:

  • Meets DSM-IV criteria for BD I and II current depressive episode
  • Able to give written informed consent
  • Age \> to 18 years and \< 65 years
  • Currently suicidal as defined by a MADRS suicide item score of \> 3 or previous history of serious suicidal ideation that required hospitalization.
  • All subjects need to have normal hearing and normal/corrected-to-normal vision.

You may not qualify if:

  • Medical illness or non-psychiatric medical treatment that would likely interfere with study participation
  • Neurologic disorder, previous ECT, or history of head trauma (i.e. known structural brain lesion potentially confounding MRI results)
  • Substance abuse within the past 3 months or current substance dependence (confirmed by MINI)
  • Left-handedness
  • Contraindications to MRI (metallic implants, claustrophobia, etc.)
  • Subjects who need urgent psychiatric care requiring hospitalization (evaluated by clinicians).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bipolar Clinic and Research Program at Massachusetts General Hospital

Boston, Massachusetts, 02144, United States

Location

MeSH Terms

Conditions

Bipolar DisorderSuicidal IdeationDepression

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental DisordersSuicideSelf-Injurious BehaviorBehavioral SymptomsBehavior

Study Officials

  • Andrew A. Nierenberg, M.D.

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Psychiatry

Study Record Dates

First Submitted

December 18, 2014

First Posted

December 23, 2014

Study Start

July 14, 2014

Primary Completion

August 29, 2016

Study Completion

August 29, 2016

Last Updated

February 9, 2017

Record last verified: 2017-02

Locations